Needham cuts ServiceNow stock price target on Middle East headwinds By Investing.com

Needham cut its price target on ServiceNow to $115 from $155 while keeping a Buy rating after Q1 fiscal 2026 results, citing delayed Middle East deals, weaker-than-expected Armis contribution, and slower Core RPO growth expected in Q2. ServiceNow’s shares trade at $103.07, down 45% over six months and well below the 52-week high of $211.48. Despite the caution, Needham still sees re-acceleration potential, and consensus on Wall Street remains Strong Buy.

Analysis

The key issue is not the quarter itself but the credibility of the next two quarters as a re-acceleration story. When a software platform with subscription visibility starts citing deal timing, acquisition noise, and contract structure as explanations for guidance softness, the market usually begins discounting the quality of the remaining performance obligation bridge rather than the headline growth rate. That matters because NOW’s premium multiple depends less on current revenue growth and more on confidence that backlog conversion stays intact; any wobble there tends to compress the multiple faster than the fundamentals deteriorate.

Second-order, the market is likely to punish the mix of inorganic and delayed-demand explanations more than the underlying operating metrics suggest. If core subscription growth slows while acquired contribution inflates the RPO headline, investors will start valuing the business on ex-acquisition organic growth and lower terminal margin assumptions, especially if Armis integration pressure is visible in gross margin or opex. That creates a trap for bulls: even if delayed deals close later, the stock can stay cheap for months because the market wants proof of sustained conversion, not promises of a catch-up quarter.

The contrarian angle is that the selloff may already be pricing in a more structural deceleration than the data justify. At this point, the setup resembles a “show-me” reset: downside is increasingly about execution slippage, while upside comes from a clean beat-and-raise cycle or evidence that delayed EMEA demand is timing, not churn. If that happens, the highest beta move is likely in the next 1-2 earnings prints rather than over a multi-year horizon, because software multiples can re-rate sharply once the backlog narrative turns.

The broader beneficiary set is not obvious, but peers with cleaner organic growth and less acquisition noise should trade at a relative premium, while infrastructure vendors exposed to enterprise budget scrutiny may get dragged if NOW’s weakness is read as a spending canary. In short, this is less a fundamental collapse than a confidence event; the stock can mean-revert quickly, but only after management re-establishes that core bookings are still compounding without help from deal timing.

Key Decisions for Investors

• Avoid catching the falling knife outright; wait for either a post-earnings stabilization base or evidence of delayed-deal conversion over the next 1-2 quarters before adding long exposure to NOW.
• For existing longs, hedge with a 30-60 day NOW put spread to protect against another multiple compression leg if the market extrapolates guidance conservatism into FY26 organic growth.
• Relative-value trade: long a cleaner high-quality enterprise software name with less M&A noise versus short NOW for 1-2 quarters; the goal is to isolate multiple expansion in the cleaner name while NOW remains trapped in a show-me discount.
• If seeking upside convexity, buy NOW call spreads dated 3-6 months out only on confirmation of delayed deal closure; risk/reward improves materially if the next print removes the EMEA timing overhang.
• Monitor for any upward revision in core RPO conversion or organic subscription guidance; that would be the trigger to cover shorts and re-enter longs, as the market will likely re-rate the stock faster than the fundamentals improve.